Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study.

DFL Follicular lymphoma IgA expression epidemiology watchful waiting

Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
10 Sep 2024
Historique:
medline: 11 9 2024
pubmed: 11 9 2024
entrez: 11 9 2024
Statut: aheadofprint

Résumé

Duodenal-type follicular lymphoma (DFL) is a rare subtype classified by the 5th edition of the WHO and international consensus classifications of lymphoid neoplasms, typically presenting as localized disease with favorable outcomes. This multicenter retrospective study examines 53 Brazilian DFL patients with a median age of 58.2 years (33-85), with males comprising 50% (

Identifiants

DOI: 10.1080/10428194.2024.2401098 PMID: 39257204
pubmed: 39257204
doi: 10.1080/10428194.2024.2401098
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Auteurs

Guilherme Duffles (G)

Rede Dor Sao Luiz, Sao Paulo, Brazil.
University of Campinas, Hematology and Hemotherapy Centre, Sao Paulo, Brazil.
ORCID: 0000-0002-6058-7558

Arthur Braga (A)

Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil.

Talita Silveira (T)

Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil.

Yana Novis (Y)

Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil.

Celso Arrais (C)

Unifesp, Sao Paulo, Brazil.

Luciana Tucunduva (L)

Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil.

Ana Rita Fonseca (AR)

Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil.

Davimar Borducchi (D)

Rede Dor Sao Luiz, Sao Paulo, Brazil.
Centro Universitário da Faculdade de medicina do ABC, Sao Paulo, Brazil.

Pedro Neffa (P)

Rede Dor Sao Luiz, Sao Paulo, Brazil.
Instituto do câncer do estado de São Paulo, ICESP, Sao Paulo, Brazil.

Fernando Blumm (F)

Rede Dor Sao Luiz, Sao Paulo, Brazil.

Marianne de Castro Gonçalves (MC)

Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil.

Frederico Moreira (F)

Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.

Fabio Nucci (F)

Rede Dor Sao Luiz, Sao Paulo, Brazil.
Hospital universitário Antônio Pedro, Universidade Federal Fluminense, UFF, Niterói, Rio de Janeiro, Brazil.

Eduardo Rego (E)

Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.
Instituto Dor de pesquisa e Ensino, IDOR, Sao Paulo, Brazil.

Vanderson Rocha (V)

Rede Dor Sao Luiz, Sao Paulo, Brazil.
Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.
Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Sao Paulo, SP, Brazil.
Churchill Hospital, Oxford University, Oxford, United Kingdom.

Classifications MeSH